D Tripathi

Summary

Affiliation: University of Edinburgh
Country: UK

Publications

  1. ncbi The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations
    D Tripathi
    Centre for Liver and Digestive Disorders and Department of Medicine, Royal Infirmary of Edinburgh, UK
    Gut 51:270-4. 2002
  2. ncbi Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts
    N Kochar
    Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK
    Aliment Pharmacol Ther 28:294-303. 2008
  3. ncbi Review article: recent advances in the management of bleeding gastric varices
    D Tripathi
    Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK
    Aliment Pharmacol Ther 24:1-17. 2006
  4. ncbi Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy
    N Kochar
    Department of Hepatology, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SU, UK
    Gut 55:1617-23. 2006
  5. ncbi Transient segmental liver ischaemia after polytetrafluoroethylene transjugular intrahepatic portosystemic stent-shunt procedure
    J W Ferguson
    Department of Hepatology, Royal Infirmary of Edinburgh, Little France, Edinburgh, UK
    J Hepatol 42:145. 2005
  6. ncbi Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding
    D Tripathi
    Liver Unit, The Royal Infirmary, Edinburgh, UK
    Gut 53:431-7. 2004
  7. ncbi Review article: the management of acute variceal bleeding
    J W Ferguson
    Liver Unit, New Royal Infirmary of Edinburgh, Edinburgh, UK
    Aliment Pharmacol Ther 18:253-62. 2003
  8. ncbi Review article: a drug therapy for the prevention of variceal haemorrhage
    D Tripathi
    Liver Unit, Department of Medicine, Royal Infirmary, Edinburgh, UK
    Aliment Pharmacol Ther 15:291-310. 2001
  9. ncbi Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension
    D Tripathi
    Liver Unit, Department of Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK
    Aliment Pharmacol Ther 16:373-80. 2002
  10. ncbi Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial
    D Tripathi
    Department of Hepatology, Royal Infirmary, 51 Little France Crescent, Edinburgh EH16 4SU, UK
    Gut 55:1290-5. 2006

Detail Information

Publications11

  1. ncbi The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations
    D Tripathi
    Centre for Liver and Digestive Disorders and Department of Medicine, Royal Infirmary of Edinburgh, UK
    Gut 51:270-4. 2002
    ..Although it has been reported that gastric varices can bleed at pressures of < or = 12 mm Hg, this phenomenon has been little studied in the clinical setting...
  2. ncbi Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts
    N Kochar
    Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK
    Aliment Pharmacol Ther 28:294-303. 2008
    ..Bleeding from ectopic varices is uncommon but can be difficult to manage...
  3. ncbi Review article: recent advances in the management of bleeding gastric varices
    D Tripathi
    Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK
    Aliment Pharmacol Ther 24:1-17. 2006
    ..Shunt surgery should be considered in well-compensated patients. Splenectomy or embolization is an option in patients with segmental portal hypertension...
  4. ncbi Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy
    N Kochar
    Department of Hepatology, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SU, UK
    Gut 55:1617-23. 2006
    ..In 5%, this can be refractory to optimal medical treatment and may require shunt modification. The efficacy of shunt modification has been poorly studied...
  5. ncbi Transient segmental liver ischaemia after polytetrafluoroethylene transjugular intrahepatic portosystemic stent-shunt procedure
    J W Ferguson
    Department of Hepatology, Royal Infirmary of Edinburgh, Little France, Edinburgh, UK
    J Hepatol 42:145. 2005
  6. ncbi Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding
    D Tripathi
    Liver Unit, The Royal Infirmary, Edinburgh, UK
    Gut 53:431-7. 2004
    ....
  7. ncbi Review article: the management of acute variceal bleeding
    J W Ferguson
    Liver Unit, New Royal Infirmary of Edinburgh, Edinburgh, UK
    Aliment Pharmacol Ther 18:253-62. 2003
    ..Randomised controlled trials are required to answer these important issues...
  8. ncbi Review article: a drug therapy for the prevention of variceal haemorrhage
    D Tripathi
    Liver Unit, Department of Medicine, Royal Infirmary, Edinburgh, UK
    Aliment Pharmacol Ther 15:291-310. 2001
    ..Correlations between haemodynamic and clinical parameters are discussed. Despite the recent increase in the use of alternative endoscopic therapies, an effective and well tolerated drug remains a clinically important research goal...
  9. ncbi Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension
    D Tripathi
    Liver Unit, Department of Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK
    Aliment Pharmacol Ther 16:373-80. 2002
    ..Carvedilol is a non-selective vasodilating beta-blocker with weak alpha1 receptor antagonism. Recent studies have demonstrated its potential as a portal hypotensive agent...
  10. ncbi Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial
    D Tripathi
    Department of Hepatology, Royal Infirmary, 51 Little France Crescent, Edinburgh EH16 4SU, UK
    Gut 55:1290-5. 2006
    ..The aim of this study was to assess the systemic and portal haemodynamic effects of selective ET-A and ET-B receptor antagonism in patients with cirrhosis...
  11. ncbi Gastric wall invasion following transjugular intrahepatic portosystemic stent shunt insertion for variceal bleeding
    D Tripathi
    Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, Scotland
    Endoscopy 38:545. 2006